{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T22:55:50Z","timestamp":1773442550120,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","pediatricnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Nursing"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.pedn.2022.06.006","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T05:51:20Z","timestamp":1656049880000},"page":"136-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Optimizing antiemetic therapy for children undergoing chemotherapy"],"prefix":"10.1016","volume":"66","author":[{"given":"Mya","family":"Merrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.pedn.2022.06.006_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00520-018-4131-3","article-title":"CINV: Still troubling patients after all these years","volume":"26","author":"Aapro","year":"2018","journal-title":"Supportive Care in Cancer"},{"issue":"1","key":"10.1016\/j.pedn.2022.06.006_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00258206","article-title":"High-dose dexamethasone for prevention of cis-platin-induced vomiting","volume":"7","author":"Aapro","year":"1981","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"7","key":"10.1016\/j.pedn.2022.06.006_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11864-019-0659-9","article-title":"Should oncologists recommend Cannabis?","volume":"20","author":"Abrams","year":"2019","journal-title":"Current Treatment Options in Oncology"},{"issue":"6","key":"10.1016\/j.pedn.2022.06.006_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00001610-200511000-00003","article-title":"The pathophysiology of chemotherapy-induced nausea and vomiting","volume":"28","author":"Baker","year":"2005","journal-title":"Gastroenterology Nursing"},{"issue":"3","key":"10.1016\/j.pedn.2022.06.006_bb0025","first-page":"303","article-title":"Management of patients with chemotherapy-induced nausea and vomiting","volume":"8","author":"Barbour","year":"2017","journal-title":"Journal of the Advanced Practitioner in Oncology"},{"issue":"6","key":"10.1016\/j.pedn.2022.06.006_bb0030","doi-asserted-by":"crossref","first-page":"e1542","DOI":"10.1542\/peds.2010-1410","article-title":"Development and validation of a pictorial nausea rating scale for children","volume":"127","author":"Baxter","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedn.2022.06.006_bb0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12094-012-0818-y","article-title":"Chemotherapy-induced nausea and vomiting: Pathophysiology and therapeutic principles","volume":"14","author":"Bayo","year":"2012","journal-title":"Clinical and Translational Oncology"},{"issue":"2","key":"10.1016\/j.pedn.2022.06.006_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cpt.598","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron","volume":"102","author":"Bell","year":"2017","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.pedn.2022.06.006_bb0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/SPC.0000000000000206","article-title":"Cancer and chemotherapy-induced nausea and vomiting: A focus on olanzapine","volume":"10","author":"Bosnjak","year":"2016","journal-title":"Current Opinion in Supportive and Palliative Care"},{"key":"10.1016\/j.pedn.2022.06.006_bb0050","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.2147\/DDDT.S214264","article-title":"Efficacy, safety and feasibility of antiemetic prophylaxis with fosaprepitant, granisetron and dexamethasone in pediatric patients with hemato-oncological malignancies","volume":"13","author":"Cabanillas Stanchi","year":"2019","journal-title":"Drug Design, Development and Therapy"},{"issue":"4","key":"10.1016\/j.pedn.2022.06.006_bb0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00432-020-03143-8","article-title":"Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"146","author":"Cabanillas Stanchi","year":"2020","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"4","key":"10.1016\/j.pedn.2022.06.006_bb0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MPH.0000000000001357","article-title":"Palonosetron is a better choice compared with ondansetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in a resource-limited pediatric oncology center: Results from a randomized control trial","volume":"41","author":"Chaudhary","year":"2019","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"6","key":"10.1016\/j.pedn.2022.06.006_bb0065","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","article-title":"The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting","volume":"28","author":"Dranitsaris","year":"2017","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.pedn.2022.06.006_bb0070","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/pbc.24508","article-title":"Guideline for prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients","volume":"60","author":"Dupuis","year":"2013","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1016\/j.pedn.2022.06.006_bb0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jnci\/djx250","article-title":"Validation of the symptom screening in pediatrics tool in children receiving cancer treatments","volume":"110","author":"Dupuis","year":"2018","journal-title":"Journal of the National Cancer Institute"},{"issue":"9","key":"10.1016\/j.pedn.2022.06.006_bb0080","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1592\/phco.26.9.1221","article-title":"Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents","volume":"26","author":"Dupuis","year":"2006","journal-title":"Pharmotherapy"},{"issue":"4","key":"10.1016\/j.pedn.2022.06.006_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27584","article-title":"Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy","volume":"66","author":"Dupuis","year":"2019","journal-title":"Pediatric Blood & Cancer"},{"issue":"1","key":"10.1016\/j.pedn.2022.06.006_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.6004\/jnccn.2007.0006","article-title":"Behavioral interventions in treating anticipatory nausea and vomiting","volume":"5","author":"Figueroa-Moseley","year":"2007","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"issue":"2","key":"10.1016\/j.pedn.2022.06.006_bb0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00520-017-3864-8","article-title":"Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: A multi-center, feasibility study","volume":"26","author":"Flank","year":"2018","journal-title":"Supportive Care in Cancer"},{"key":"10.1016\/j.pedn.2022.06.006_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00003495-199855020-00002","article-title":"5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting: A comparison of their pharmacology and clinical efficacy","volume":"55","author":"Gregory","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.pedn.2022.06.006_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2020.100278","article-title":"Chemotherapy-induced nausea and vomiting: Pathogenesis, recommendations, and new trends","volume":"26","author":"Gupta","year":"2021","journal-title":"Cancer Treatment and Research Communications"},{"issue":"1","key":"10.1016\/j.pedn.2022.06.006_bb0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1188\/09.CJON.54-64","article-title":"Chemotherapy-induced nausea and vomiting: Challenges and opportunities for improved patient outcomes","volume":"13","author":"Hawkins","year":"2009","journal-title":"Clinical Journal of Oncology Nursing"},{"key":"10.1016\/j.pedn.2022.06.006_bb0115","author":"Hematology\/Oncology Pharmacy Association, Eisai Inc, & Helsinn Therapeutics (U.S)"},{"issue":"24","key":"10.1016\/j.pedn.2022.06.006_bb0120","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1200\/JCO.20.01296","article-title":"Antiemetics: American Society of Clinical Oncology guideline update","volume":"38","author":"Hesketh","year":"2020","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/j.pedn.2022.06.006_bb0125","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.aco.0000247340.61815.38","article-title":"Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting","volume":"19","author":"Ho","year":"2006","journal-title":"Current Opinion in Anaesthesiology"},{"key":"10.1016\/j.pedn.2022.06.006_bb0130","unstructured":"ISMP 2020-2021 targeted medication safety best practices for hospitals. (2021). Retrieved May 24, 2022, from https:\/\/www.ismp.org\/sites\/default\/files\/attachments\/2020-02\/20202021%20TMSBP-%20FINAL_1.pdf"},{"issue":"4","key":"10.1016\/j.pedn.2022.06.006_bb0135","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00520-022-06818-9","article-title":"Pharmacogenetic and clinical predictors of ondansetron failure in a diverse pediatric oncology population","volume":"30","author":"Jacobs","year":"2022","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"10.1016\/j.pedn.2022.06.006_bb0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(15)70061-6","article-title":"Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: A randomised, double-blind, phase 3 trial","volume":"16","author":"Kang","year":"2015","journal-title":"The Lancet. Oncology"},{"key":"10.1016\/j.pedn.2022.06.006_bb0145","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"key":"10.1016\/j.pedn.2022.06.006_bb0150","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"key":"10.1016\/j.pedn.2022.06.006_bb0155","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"key":"10.1016\/j.pedn.2022.06.006_bb0160","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"key":"10.1016\/j.pedn.2022.06.006_bb0165","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"key":"10.1016\/j.pedn.2022.06.006_bb0170","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"key":"10.1016\/j.pedn.2022.06.006_bb0175","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"key":"10.1016\/j.pedn.2022.06.006_bb0180","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"key":"10.1016\/j.pedn.2022.06.006_bb0185","author":"Lexi-comp Online, Pediatric and Neonatal Lexi-Drugs Online"},{"issue":"2","key":"10.1016\/j.pedn.2022.06.006_bb0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/PPO.0b013e31816a0f07","article-title":"Chemotherapy-induced nausea and vomiting","volume":"14","author":"Lohr","year":"2008","journal-title":"The Cancer Journal"},{"issue":"6","key":"10.1016\/j.pedn.2022.06.006_bb0195","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1177\/1078155219892666","article-title":"Integration of a nausea and vomiting assessment tool into antineoplastic management of pediatric oncology patients","volume":"26","author":"McKinnon","year":"2020","journal-title":"Journal of Oncology Pharmacy Practice"},{"issue":"3","key":"10.1016\/j.pedn.2022.06.006_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/1043454216688638","article-title":"Integrative therapeutic approaches for the management and control of nausea in children undergoing cancer treatment: A systematic review of literature","volume":"34","author":"Momani","year":"2017","journal-title":"Journal of Pediatric Oncology Nursing"},{"issue":"6","key":"10.1016\/j.pedn.2022.06.006_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27690","article-title":"Pharmacokinetics\/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric cancer patients","volume":"66","author":"Mora","year":"2019","journal-title":"Pediatric Blood & Cancer"},{"issue":"32","key":"10.1016\/j.pedn.2022.06.006_bb0210","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1200\/JCO.20.00871","article-title":"Olanzapine for prevention of vomiting in children and adolescents receiving highly emetogenic chemotherapy: Investigator-initiated, randomized, open-label trial","volume":"38","author":"Naik","year":"2020","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pedn.2022.06.006_bb0215","series-title":"Antiemesis. NCCN guidelines V2","first-page":"2022","article-title":"Clinical practice guidelines in oncology","author":"National Comprehensive Cancer Network","year":"2022"},{"key":"10.1016\/j.pedn.2022.06.006_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40272-017-0228-2","article-title":"Management of chemotherapy-induced nausea and vomiting in pediatric patients","volume":"19","author":"Navari","year":"2017","journal-title":"Pediatric Drugs"},{"issue":"14","key":"10.1016\/j.pedn.2022.06.006_bb0225","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.pedn.2022.06.006_bb0230","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/bcp.13322","article-title":"Aprepitant and fosaprepitant drug interactions: A systematic review","volume":"83","author":"Patel","year":"2017","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1016\/j.pedn.2022.06.006_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26542","article-title":"Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update","volume":"64","author":"Patel","year":"2017","journal-title":"Pediatric Blood & Cancer"},{"issue":"5","key":"10.1016\/j.pedn.2022.06.006_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27646","article-title":"Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline","volume":"66","author":"Paw Cho Sing","year":"2019","journal-title":"Pediatric Blood & Cancer"},{"issue":"3","key":"10.1016\/j.pedn.2022.06.006_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27551","article-title":"Intravenous fosaprepitant for the prevention of chemotherapy-induced vomiting in children: A double-blind, placebo-controlled, phase III randomized trial","volume":"66","author":"Radhakrishnan","year":"2019","journal-title":"Pediatric Blood & Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.pedn.2022.06.006_bb0250","doi-asserted-by":"crossref","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila","year":"2016","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1016\/j.pedn.2022.06.006_bb0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/jayao.2020.0021","article-title":"Dronabinol prescribing and exposure among children and young adults diagnosed with cancer","volume":"10","author":"Rower","year":"2021","journal-title":"Journal of Adolescent and Young Adult Oncology"},{"issue":"3","key":"10.1016\/j.pedn.2022.06.006_bb0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ped.13780","article-title":"Evaluation of aprepitant and fosaprepitant in pediatric patients","volume":"61","author":"Saito","year":"2019","journal-title":"Pediatrics International"},{"key":"10.1016\/j.pedn.2022.06.006_bb0265","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fphar.2018.00913","article-title":"A history of drug discovery for treatment of nausea and vomiting and the implications for future research","volume":"9","author":"Sanger","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pedn.2022.06.006_bb0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11912-019-0840-0","article-title":"Latest update on prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients","volume":"21","author":"Sherani","year":"2019","journal-title":"Current Oncology Reports"},{"key":"10.1016\/j.pedn.2022.06.006_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2015.12.001","article-title":"Impact of chemotherapy- induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review","volume":"99","author":"Sommariva","year":"2016","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"2","key":"10.1016\/j.pedn.2022.06.006_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26815","article-title":"Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy","volume":"65","author":"Tan","year":"2018","journal-title":"Pediatric Blood & Cancer"},{"issue":"1","key":"10.1016\/j.pedn.2022.06.006_bb0285","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12916-016-0761-9","article-title":"Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: A systematic review and network meta-analysis","volume":"14","author":"Tricco","year":"2016","journal-title":"BMC Medicine"},{"key":"10.1016\/j.pedn.2022.06.006_bb0290","first-page":"136","article-title":"Optimum management of nausea and vomiting in cancer chemotherapy","volume":"24","author":"Triozzi","year":"1987","journal-title":"Practical Therapeutics"},{"issue":"6","key":"10.1016\/j.pedn.2022.06.006_bb0295","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1213\/ANE.0000000000003850","article-title":"Clinical use of the pictorial Baxter retching faces scale for measurement of postoperative nausea in children","volume":"128","author":"Watcha","year":"2019","journal-title":"Anesthesia and Analgesia"},{"issue":"1","key":"10.1016\/j.pedn.2022.06.006_bb0300","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1186\/s12885-019-6252-6","article-title":"Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study","volume":"19","author":"Willier","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Journal of Pediatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882596322001518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882596322001518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:27:53Z","timestamp":1760113673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882596322001518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":60,"alternative-id":["S0882596322001518"],"URL":"https:\/\/doi.org\/10.1016\/j.pedn.2022.06.006","relation":{},"ISSN":["0882-5963"],"issn-type":[{"value":"0882-5963","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing antiemetic therapy for children undergoing chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedn.2022.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}